A massive overhaul of staffing and review processes have left the agency appearing heavily driven by the Trump administration ...
The decision comes more than a year after disappointing initial Phase 3 results and casts further doubt on a class of ...
The deal, which involves up to 8 “next-generation” weight loss medications and could be worth more than $18 billion, ranks as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results